ENTA
#3068
Enanta Pharmaceuticals, Inc. - Common Stock
13.5 1 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.35%
Monthly Change
+6.38%
6 month change
-6.70%
Year Change
+49.12%
Previous Close
13.3 3
Open
13.5 1
Low
13.5 1
High
13.5 1
Volume
42
Financials
- Market Capitalization 393.48 M
- Employee 120
- Founded 1995
- CEO N/A
- Website www.enanta.com
- Headquarter Massachusetts, United States
- FIGI BBG001V9NSB4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.02
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3051 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.07 USD | +0.74% | -2.16% | +1.50% | +37.04% | 403.53 M USD | ||
| 3064 |  EYPT EyePoint, Inc. - Common Stock | 4.58 USD | +1.78% | -8.76% | -62.88% | -61.83% | 394.85 M USD | ||
| 3088 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.70 USD | -1.26% | -7.84% | +13.25% | -1.88% | 385.62 M USD | ||
| 3097 |  CTNM Contineum Therapeutics, Inc. - Common stock | 16.55 USD | +1.91% | -2.53% | +8.74% | +8.38% | 382.29 M USD |
Frequently asked questions about Enanta Pharmaceuticals, Inc
What is the Enanta Pharmaceuticals, Inc stock price today?
The current price of Enanta Pharmaceuticals, Inc (ENTA) is 13.51. Over the past 24 hours, the stock has changed by +1.35%. Follow the ENTA chart for real-time price dynamics.
What is the stock ticker of Enanta Pharmaceuticals, Inc?
Enanta Pharmaceuticals, Inc trades under the ticker ENTA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Enanta Pharmaceuticals, Inc stock going up?
ENTA has changed by -3.50% over the last week, +6.38% over the last month, and +49.12% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Enanta Pharmaceuticals, Inc?
Enanta Pharmaceuticals, Inc currently has a market capitalization of 393.48 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Enanta Pharmaceuticals, Inc earnings last quarter?
Last quarter, Enanta Pharmaceuticals, Inc reported earnings of -0.67 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Enanta Pharmaceuticals, Inc revenue for the last quarter?
Enanta Pharmaceuticals, Inc reported quarterly revenue of 14.36 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Enanta Pharmaceuticals, Inc net income for the last quarter?
Enanta Pharmaceuticals, Inc reported net income of -19.5 M for the last quarter. The previous quarter showed -13.09 M, which means net income changed by -48.96%.
How many employees does Enanta Pharmaceuticals, Inc have?
As of the latest available data, Enanta Pharmaceuticals, Inc has 120 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Enanta Pharmaceuticals, Inc stock?
You can buy Enanta Pharmaceuticals, Inc (ENTA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Enanta Pharmaceuticals, Inc stock?
Investing in Enanta Pharmaceuticals, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENTA chart and related analysis on metatrader.com as part of your research.